相关实验视频

Updated: May 6, 2026

Quantification of Atherosclerotic Plaque Activity and Vascular Inflammation using [18-F] Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography FDG-PET/CT

Quantification of Atherosclerotic Plaque Activity and Vascular Inflammation using [18-F] Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography FDG-PET/CT

Published on: May 2, 2012

2-[¹⁸F] FDG PET/CT 在快速晚发多重乙-CoA脱酶缺乏症:一个案例报告

Astrid Høj¹, Sonja Holm-Yildiz¹, Thomas Krag¹

¹Department of Neurology, Copenhagen Neuromuscular Centre Copenhagen University Hospital, Rigshospitalet Copenhagen Denmark.

|February 14, 2025

概括

多重乙-CoA脱酶缺乏症 (MADD) 是一种罕见的代谢肌肉病变. 一个2-[18F] FDG PET/CT扫描有助于诊断出一个快速,晚发的MADD病例,导致治疗显著恢复.

科学领域:

神经学神经学
代谢障碍代谢障碍代谢障碍
医疗成像医学成像

背景情况:

多重乙-CoA脱酶缺乏症 (MADD) 是一种罕见的遗传代谢肌病.
晚期发病的MADD通常表现为运动不耐受和肌肉虚弱.
这一案例突出显示了52岁的急性,非常晚发的MADD表现.

研究的目的:

为了呈现一个快速,晚期发作的多重乙-CoA脱酶缺乏症的独特案例.
评估 2-[18F] FDG PET/CT 在疑似代谢性肌肉病变中的诊断效用.
为了证明早期饮食和补充治疗MADD的疗效.

主要方法:

一个52岁的患者的临床表现和诊断工作,肌肉迅速恶化.
使用了2-[18F] FDG PET/CT,用Oil Red O染色进行肌肉活检,并进行乙甲胺分析.
通过对ETFDH基因的基因分析确认了诊断,并评估了治疗反应.

主要成果:

患者表现出迅速的衰退,模仿神经和炎症性肌肉病变.
2-[18F] FDG PET/CT显示了扩散的,对称的肌肉吸收,表明代谢性肌肉病变.
用利博弗拉,利沃卡尼丁和CoQ10治疗导致在一个月内几乎完全康复.

结论:

2-[18F] FDG PET/CT可以成为诊断罕见代谢性肌肉病症 (如MADD) 的宝贵工具.
早期诊断和干预,包括饮食改变和补充剂,对于MADD至关重要.
这一案例强调了在晚期开始的肌肉衰弱中考虑代谢性肌肉病变的重要性.

关键词:

在FDG PET/CT中使用PET/CT.麦德德是个疯狂的人.脂质肌病症是什么脂质肌病症是什么代谢性肌肉病变 - 代谢性肌肉病变多重乙辅酶-A脱原酶缺乏症肌肉活组织活检肌肉活检

更多相关视频

Determining Glucose Metabolism Kinetics Using 18F-FDG Micro-PET/CT

Determining Glucose Metabolism Kinetics Using 18F-FDG Micro-PET/CT

Published on: May 2, 2017

Gene Regulation and Targeted Therapy in Gastric Cancer Peritoneal Metastasis: Radiological Findings from Dual Energy CT and PET/CT

Gene Regulation and Targeted Therapy in Gastric Cancer Peritoneal Metastasis: Radiological Findings from Dual Energy CT and PET/CT

Published on: January 22, 2018

相关概念视频

Positron Emission Tomography

Positron Emission Tomography

Positron emission tomography (PET) is a medical imaging technique involving radiopharmaceuticals — substances that emit short-lived radiation. Although the first PET scanner was introduced in 1961, it took 15 more years before radiopharmaceuticals were combined with the technique and revolutionized its potential.
One of the main requirements of a PET scan is a positron-emitting radioisotope, which is produced in a cyclotron and then attached to a substance used by the part of the body...